Psychemedics Corp
PMDDelisted Dec 13, 2024- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000806517
Psychemedics Corp was delisted on Dec 13, 2024; its insiders filed their last Form 4 on Dec 17, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $2.85M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Psychemedics Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q1 2022
- Shares held
- 1.50M
- −94.9K (−5.9%) vs. Q1 2022
- Total value
- $9.55M
- −$1.30M (−11.9%) vs. Q1 2022
- New holders
- 0
- 6 more added
- Sold out
- 3
- 7 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $441.7K |
| Q3 2025 | 1 | $582.4K |
| Q2 2025 | 1 | $618.3K |
| Q1 2025 | 1 | $643.2K |
| Q4 2024 | 3 | $708.7K |
| Q3 2024 | 21 | $2.85M |
| Q2 2024 | 26 | $2.87M |
| Q1 2024 | 22 | $3.54M |
| Q4 2023 | 23 | $3.82M |
| Q3 2023 | 25 | $5.68M |
| Q2 2023 | 21 | $6.32M |
| Q1 2023 | 20 | $7.34M |
| Q4 2022 | 22 | $6.93M |
| Q3 2022 | 23 | $9.54M |
| Q2 2022 | 21 | $9.55M |
| Q1 2022 | 25 | $11.0M |
| Q4 2021 | 25 | $11.4M |
| Q3 2021 | 28 | $13.9M |
| Q2 2021 | 28 | $12.4M |
| Q1 2021 | 31 | $11.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Psychemedics Corp; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 33 | $0 | 0.00% | +3+10.0% | Added |
| FMR LLC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 125 | $1.00K | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 150 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 510 | $3.00K | 0.00% | −1,236−70.8% | Reduced |
| Tower Research Capital LLC (TRC) | 1,185 | $7.00K | 0.00% | −385−24.5% | Reduced |
| State Street Corp | 16,162 | $102.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,346 | $110.0K | 0.00% | −1,410−7.5% | Reduced |
| Morgan Stanley | 19,157 | $122.0K | 0.00% | +14,141+281.9% | Added |
| Santa Monica Partners LP | 20,000 | $127.0K | 0.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 35,304 | $223.0K | 0.00% | +686+2.0% | Added |
| Invenomic Capital Management LP | 43,560 | $276.0K | 0.02% | −92,071−67.9% | Reduced |
| Wealth Effects LLC | 45,301 | $287.0K | 0.17% | +5,300+13.2% | Added |
| Dimensional Fund Advisors LP | 59,829 | $379.0K | 0.00% | −478−0.8% | Reduced |
| Ancora Advisors, LLC | 80,728 | $512.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 87,007 | $552.0K | 0.00% | −1,409−1.6% | Reduced |
| Cannell Capital LLC | 89,211 | $566.0K | 0.11% | +10,905+13.9% | Added |
| RBF Capital, LLC | 144,231 | $952.0K | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 247,340 | $1.57M | 0.00% | 00.0% | Unchanged |
| Crawford Investment Counsel Inc | 267,309 | $1.70M | 0.04% | +807+0.3% | Added |
| Renaissance Technologies LLC | 326,167 | $2.07M | 0.00% | −15,255−4.5% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,910−100.0% | Sold out |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −2,039−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |